Ligand profile
GMZ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4017 — bifunctional protein RfaE, domain I
Identifiers
Database identifiers and provenance.
- Ligand ID
GMZ- PDB
4e84- UniProt (similar protein)
B4EB35- Target protein
- VK055_4017
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 223.7
- −1 ≤ LogP ≤ 5 -3.63
- MW ≤ 500 Da 370.1
- LogP ≤ 5 -3.63
- H-bond donors ≤ 5 8
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 223.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C([C@H]([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)OP(=O)(O)O)O)O)O)O)OP(=O)(O)OC([C@H]([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)OP(=O)(O)O)O)O)O)O)OP(=O)(O)O
InChI=1S/C7H16O13P2/c8-2(1-18-21(12,13)14)6-4(10)3(9)5(11)7(19-6)20-22(15,16)17/h2-11H,1H2,(H2,12,13,14)(H2,15,16,17)/t2-,3+,4+,5+,6-,7+/m1/s1InChI=1S/C7H16O13P2/c8-2(1-18-21(12,13)14)6-4(10)3(9)5(11)7(19-6)20-22(15,16)17/h2-11H,1H2,(H2,12,13,14)(H2,15,16,17)/t2-,3+,4+,5+,6-,7+/m1/s1
LMTGTTLGDUACSJ-QTNLNCNHSA-NLMTGTTLGDUACSJ-QTNLNCNHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00294
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand GMZ →
- PDB RCSB structure 4e84 →
- UniProt UniProt B4EB35 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “GMZ”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4017.
PDB 9
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).